Journal of Cardiac Failure
Volume 15, Issue 7 , Pages 629-636, September 2009

A Synthetic Non-degradable Polyethylene Glycol Hydrogel Retards Adverse Post-infarct Left Ventricular Remodeling

  • Stephan Dobner, MD
  • ,
  • Deon Bezuidenhout, PhD
  • ,
  • Padmini Govender, MSc
  • ,
  • Peter Zilla, MD, PhD
  • ,
  • Neil Davies, PhD

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr. Neil Davies, Cardiovascular Research Unit, Chris Barnard Division of Cardiothoracic Surgery, University of Cape Town Department of Health Sciences, 203 Cape Heart Centre, Anzio Road, Observatory, 7925, Cape Town, South Africa. Fax: +27 21 448 5935.

Cardiovascular Research Unit, Chris Barnard Division of Cardiothoracic Surgery, University of Cape Town Department of Health Sciences, Cape Town, South Africa

Received 6 October 2008; received in revised form 13 March 2009; accepted 17 March 2009. published online 08 May 2009.

Abstract 

Background

Left ventricular remodeling after myocardial infarction is a key component of heart failure and it has long been postulated that it may result from increased wall stress. It has recently been suggested that an injectable, non-degradable polymer may limit pathological remodeling in a manner analogous to that of cardiac support devices. We have tested a non-degradable polyethylene glycol (PEG) gel in a rat infarction model.

Methods and Results

After permanent ligation of the left anterior descending artery in male Wistar rats, PEG gel reagents were injected into the infarcted region and polymerized in situ. At 4 weeks, fractional shortening and infarct volume were unchanged relative to a saline injected control, but the infarct-induced left ventricular end-diastolic diameter (LVEDD) increase was substantially reduced (43%, P < .05) and wall thinning was completely prevented. At 13 weeks, the LVEDD were similar for both saline- and PEG-injected hearts. The non-degradable PEG gels did elicit a macrophage-based inflammatory reaction.

Conclusions

The injection of non-degradable synthetic gel was effective in ameliorating pathological remodeling in the immediate postinfarction healing phase, but was unable to prevent the dilation that occurred at later stages in the healed heart.

Key Words: Myocardial infarction biomaterial

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by collaborative funding from Medtronic Inc., and by a grant from the Technology and Human Resources for Industry Program (THRIP) TP2007080700007, National Research Foundation, South Africa.

PII: S1071-9164(09)00096-7

doi:10.1016/j.cardfail.2009.03.003

Journal of Cardiac Failure
Volume 15, Issue 7 , Pages 629-636, September 2009